Chemical Structure : AZD3514
CAS No.: 1240299-33-5
Catalog No.: PC-25059Not For Human Use, Lab Use Only.
AZD3514 is an orally bioavailable small-molecule androgen receptor downregulator with pIC50 of 5.75, inhibits androgen-dependent and -independent AR signaling.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $58 | In stock | |
10 mg | $88 | In stock | |
25 mg | $148 | In stock | |
50 mg | $238 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AZD3514 is an orally bioavailable small-molecule androgen receptor downregulator with pIC50 of 5.75, inhibits androgen-dependent and -independent AR signaling.
AZD3514 modulates AR signaling through two distinct mechanisms, an inhibition of ligand-driven nuclear translocation of AR and a downregulation of receptor levels, both of which were observed in vitro and in vivo.
AZD3514 inhibited testosterone-driven seminal vesicle development in juvenile male rats and the growth of androgen-dependent Dunning R3327H prostate tumors in adult rats.
AZD3514 showed antitumor activity in the HID28 mouse model of CRPC in vivo.
M.Wt | 519.57 | |
Formula | C25H32F3N7O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethan-1-one |
1. Omlin A, et al. Invest New Drugs. 2015 Jun;33(3):679-90.
2. Loddick SA, et al. Mol Cancer Ther. 2013 Sep;12(9):1715-27.
3. Bradbury RH, et al. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1945-8.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright